Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease.
about
The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairmentHippocampal lipid differences in Alzheimer's disease: a human brain study using matrix-assisted laser desorption/ionization-imaging mass spectrometryRedox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain.Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease.Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Using neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease.Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.Oxidative stress in the progression of Alzheimer disease in the frontal cortex.Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease.Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegenerationPhosphatidylserine in the brain: metabolism and function.A network-based approach for predicting key enzymes explaining metabolite abundance alterations in a disease phenotype.Neurovascular and neurometabolic derailment in aging and Alzheimer's disease.Neuronal and vascular oxidative stress in Alzheimer's disease.Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models.The Relieving Effects of BrainPower Advanced, a Dietary Supplement, in Older Adults with Subjective Memory Complaints: A Randomized, Double-Blind, Placebo-Controlled TrialCaspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease.Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease.Antioxidants in central nervous system diseases: preclinical promise and translational challenges.Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism.Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before.Oxidative stress and β-amyloid protein in Alzheimer's disease.Cell cycle proteins in brain in mild cognitive impairment: insights into progression to Alzheimer disease.4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studiesThe neuropathological profile of mild cognitive impairment (MCI): a systematic review.Primary phagocytosis of neurons by inflamed microglia: potential roles in neurodegenerationLipidomics of Alzheimer's disease.Microglial phagocytosis of live neurons.Neuronal death induced by nanomolar amyloid β is mediated by primary phagocytosis of neurons by microglia.Antisense directed against PS-1 gene decreases brain oxidative markers in aged senescence accelerated mice (SAMP8) and reverses learning and memory impairment: a proteomics studyTet1-mediated DNA demethylation involves in neuron damage induced by bilirubin in vitro.The proton permeability of self-assembled polymersomes and their neuroprotection by enhancing a neuroprotective peptide across the blood-brain barrier after modification with lactoferrin.Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer's Disease.
P2860
Q26827320-3D9FAAAC-EAF1-449D-8FAA-16697F3D030EQ28391606-6106A1CA-2F8B-4F15-8F84-2767095514C3Q30367032-E391C1FD-1685-4F84-A9A3-B147D3C6D2C9Q30394816-A0100DDE-5E2D-49AD-834E-AD2CC1480C9BQ30446460-78811358-967F-408B-9EA0-A93A942A4D8AQ30451918-DC6C36EC-0142-41A8-B05A-7A43CA0228C6Q33506441-B032A9CB-0736-40B8-9664-CD4D971C91AAQ33639885-6AD32904-1824-4124-B959-0F948169DF37Q33680790-D7CAB0EC-CA32-408C-9235-3084267176D9Q33712475-7E86D610-7F47-4D3F-BDCA-91E43A057670Q33915362-DBE595F0-9605-4B4B-B4C6-A7776CA9DC1CQ34071097-C0A3D5D3-703F-4238-8365-70A983966593Q34647336-3CC64B3C-2AA8-4ADD-8E3C-F2FFD5F3F016Q34839535-55C54F9E-4C32-4ECE-815E-2634677A0F1EQ35651255-F78C6D27-96E5-424A-8134-22F1352ED0DAQ35687039-DA5B4DE9-396E-48E7-87AA-47A5B015F889Q36761675-51E010C3-85EF-4A0C-A36E-E76958DC92C9Q36829198-6F2D786A-F0FA-4937-A94E-E189795A74CFQ36943100-8BC4D8C9-C1A1-49C9-BCC9-1C3F956F0D0DQ37075304-7F6C22DD-302B-4778-A519-725B3390A10BQ37159979-3F140DCE-F118-453C-943F-960F7A7640D2Q37603401-09C099D0-5B7A-498A-B69F-57550FBD7CE9Q37910243-2735D85D-FFBA-474B-8BF5-8719D4960BC0Q37928994-97646FB1-0F91-4C3C-BC4C-4D853ECE7EDAQ37956168-9C2A0025-ED31-457A-B553-423F3B5C6DF7Q37960537-3E1ABBA7-D291-4967-9491-DEC3A387E1F1Q37964897-9CA71852-4487-4911-A591-F3ED15DA6E91Q37992053-276937F9-831E-487C-A0A8-5E0243167BC4Q38191024-8B65AFF1-CC4F-47F1-853B-6B65B2300BA3Q38197408-15DAFC5D-EFEE-4F94-A9FE-7E269D4CB11FQ39246322-08E2AF31-134C-4AD7-BBE5-BEE982DE1143Q41870228-B5408883-2532-4BA3-BF27-E35E2ED19EB9Q46321546-6CEAA550-DD24-4BEC-B1C3-2897EE6E4AFCQ50690250-19CFE7E5-1A1C-42B5-B3FE-0C2F25037A8DQ51760895-F9B6F8EB-4AE1-40FD-83A8-B193BE88D56F
P2860
Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Loss of phospholipid asymmetry ...... airment and Alzheimer disease.
@ast
Loss of phospholipid asymmetry ...... airment and Alzheimer disease.
@en
type
label
Loss of phospholipid asymmetry ...... airment and Alzheimer disease.
@ast
Loss of phospholipid asymmetry ...... airment and Alzheimer disease.
@en
prefLabel
Loss of phospholipid asymmetry ...... airment and Alzheimer disease.
@ast
Loss of phospholipid asymmetry ...... airment and Alzheimer disease.
@en
P2093
P2860
P50
P1476
Loss of phospholipid asymmetry ...... airment and Alzheimer disease.
@en
P2093
Hafiz Mohmmad Abdul
Miranda L Bader Lange
Rukhsana Sultana
P2860
P304
P356
10.1016/J.NBD.2007.11.004
P577
2007-11-12T00:00:00Z